A clinical trial to study the effectiveness of minocycline 4% gel in mild to moderate facial acne
Phase 3
- Conditions
- Health Condition 1: L700- Acne vulgaris
- Registration Number
- CTRI/2023/06/053579
- Lead Sponsor
- Institute of Post Graduate Medical Education and Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients above 18 years of age having minimum of 10 facial lesions on each side of
face (including both non-inflammatory and inflammatory acne) and have not received
any systemic or topical acne treatment in last 4 weeks.
Exclusion Criteria
Patients with nodulo-cystic acne lesions.
Pregnant and lactating patients.
Patients with severe psychiatric illness.
Patients with major systemic illness or severe co-morbidities.
Patients on anti-coagulant or immunosuppressive therapy.
Patients with history of allergic reaction to tetracycline group of drugs.
Patients having history of systemic retinoid therapy in last 6 months.
Patients with concomitant use of photosensitizing or neuromuscular blocking agents.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of acne lesions over each half of face is counted at baseline and then at every visitTimepoint: Patient is asked to follow up after 2 weeks, 4 weeks and 8 weeks.
- Secondary Outcome Measures
Name Time Method